- Drug Labeling Status of Culprit Drugs Inducing Severe Cutaneous Adverse Reactions
-
Yeom HJ, Kim HHw, Kim HJ, Park S, Jang JY, Park GY, Kang DY, Kang HR
- KMID: 2534651
- J Pharmacoepidemiol Risk Manage.
- 2021 Sep;13(2):70-77.
- doi: 10.56142/2021.13.2.70
Objective: The labeling status of culprit drugs of Severe Cutaneous Adverse Reactions (SCAR) was evaluated by comparing the labeling status of the US Food and Drug Administration (FDA) to the... -
- CITED
-
- Close
- SHARE
-
- Close
